Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Posted on by Pencis

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Auckland University of Technology | New Zealand.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Mr. Silas Adjei–Gyamfi began his academic journey with a profound interest in microbiology and infectious diseases, laying a strong foundation in biomedical science. His early studies were marked by academic excellence and scientific curiosity, leading him to pursue specialized training in pathogen biology, clinical microbiology, and molecular epidemiology.

💼PROFESSIONAL ENDEAVORS

Mr. Adjei–Gyamfi has consistently bridged the gap between theory and practice, applying his scientific expertise in a variety of clinical, research, and public health settings. His roles have included positions in academic laboratories, national health institutes, and international health organizations, where he has contributed to infectious disease diagnostics, control, and policy formulation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES

A core focus of Mr. Adjei–Gyamfi’s career has been on infectious disease surveillance, diagnostics, and prevention. His contributions span several critical areas:

  • Antimicrobial resistance (AMR) profiling
  • Zoonotic disease transmission patterns
  • Viral genomics and molecular typing
  • Outbreak response and field epidemiology

He is recognized for implementing innovative diagnostic technologies, such as real-time PCR, serological assays, and pathogen genome sequencing, to improve early detection and containment of outbreaks.

🌍IMPACT AND INFLUENCE

Mr. Adjei–Gyamfi’s research and leadership have directly influenced public health responses to infectious disease threats in sub-Saharan Africa and beyond. He has played instrumental roles in cross-border health initiatives, community-level disease education, and data-driven decision-making in epidemic control.

🏆RESEARCH GRANTS AND FUNDING

Mr. Adjei–Gyamfi has successfully secured competitive research funding from national and international agencies, including:

  • World Health Organization (WHO) initiatives
  • Global Fund-supported projects
  • National Institutes of Health (NIH) collaborations
  • Africa CDC and regional grants

These funds have supported capacity-building in diagnostics, community surveillance programs, and field research into infectious disease ecology.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Mr. Adjei–Gyamfi aims to build sustainable health research systems in low-resource settings. His future initiatives include:

  • Establishing infectious disease reference centers

  • Developing AI-driven surveillance platforms

  • Training young scientists in Africa in biosecurity and epidemiology

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Silas Adjei–Gyamfi embodies the spirit of innovation, resilience, and service in the infectious disease field. With a career marked by scientific integrity, collaborative leadership, and community-centered approaches, he continues to shape health outcomes at local and global levels.

📑NOTABLE PUBLICATIONS

Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana

Authors: Adjei-Gyamfi, Silas; Asirifi, Abigail; Asobuno, Clotilda; Korang, Felix Kwame
Year: 2025
Journal: PLoS ONE

Risk factors for anaemia among pregnant women: A cross-sectional study in Upper East Region, Ghana

Authors: Asobuno, C.; Adjei-Gyamfi, S.; Aabebe, F.G.; Hammond, J.; Taikeophithoun, C.; Amunah, N.; Aoki, T.; Aiga, H.
Year: 2024
Journal: PLoS ONE​

Anaemia at 36 weeks of pregnancy: Prevalence and determinants among antenatal women attending peri-urban facilities in a developing country, Ghana

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Peprah, W.; Abbey, D.A.; Hamenoo, K.W.; Zakaria, M.S.; Mohammed, O.; Aryee, P.A.
Year: 2024
Journal: PLOS Global Public Health

Maternal anaemia and polycythaemia during pregnancy and risk of inappropriate birthweight for gestational age babies: A retrospective cohort study in the northern belt of Ghana

Authors: Adjei-Gyamfi, S.; Zakaria, M.S.; Asirifi, A.; Sulley, I.; Ibrahim, M.A.; Aryee, P.A.
Year: 2024
Journal: BMJ Open

Prevalence and associated risk factors of preterm and post-term births in Northern Ghana: A retrospective study in Savelugu Municipality

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Aiga, H.
Year: 2023
Journal: Journal of Pediatrics, Perinatology and Child Health

Yi HSin Wang | Antibiotic | Best Researcher Award

Posted on by Pencis

Yi HSin Wang | Antibiotic | Best Researcher Award

Assist Prof Dr. Yi HSin Wang , Chung Shan Medical University, Taiwan.

Assist Prof Dr. Yi Hsin Wang is a dedicated researcher specializing in antibiotic discovery and development. With a strong academic foundation in microbiology and pharmacology, she has contributed significantly to the understanding of antibiotic resistance mechanisms and the identification of novel antimicrobial agents. Her work focuses on developing innovative strategies to combat bacterial infections, making a profound impact on public health. Yi Hsin has published numerous articles in peer-reviewed journals and has presented her research at international conferences, showcasing her commitment to advancing the field of antibiotic research. Her dedication to scientific excellence and her contributions to antibiotic development make her a deserving candidate for the Best Researcher Award.

Profile:

Scopus  Profile

Education

Assist Prof Dr. Yi-Hsin Wang pursued his academic journey at Chung Shan Medical University, beginning with a Bachelor of Science degree in Medical Applied Chemistry from 2008 to 2012. He then advanced to the Institute of Medicine at the same university, completing a Master of Science degree from 2012 to 2014 under the guidance of Professors Jinghua Tsai Chang and Shiang-Suo Huang. Building upon his research foundation, Yi-Hsin continued his studies in the Institute of Medicine, where he earned his Ph.D. from 2014 to 2018, with Professors Jinghua Tsai Chang and Shiang-Suo Huang as his advisors once again.

 

Experience 

Assist Prof Dr. Yi-Hsin Wang currently holds the position of Assistant Professor in the Department of Physiology at Chung Shan Medical University’s School of Medicine (2022.08–present). Previously, Wang served as a Postdoctoral Researcher in the Department of Pharmacology at China Shan Medical University’s School of Medicine (2019.08–2022.07) and in the Graduate Institute of Acupuncture Science at China Medical University (2018.09–2019.07), with a strong focus on physiology, pharmacology, and acupuncture science throughout their academic and research career.

 

Skills

Assist Prof Dr. Yi-Hsin Wang possesses a range of experimental skills, including expertise in creating animal models for myocardial infarction and ischemic stroke. Additionally, Wang is proficient in Western blotting, gelatin zymography, and immunohistochemistry, each essential for analyzing protein expression, enzyme activity, and tissue-specific antigen localization.

 

Awards

Assist Prof Dr. Yi-Hsin Wang has received notable awards for contributions to biomedical sciences, including the Young Scientist Travel Award at the 9th FAOPS Congress (2019) in Japan and 2nd place in the Poster Award at the 33rd Joint Annual Conference of Biomedical Sciences (2018) in Taiwan.

 

Research Skills

Assist Prof Dr. Yi-Hsin Wang research expertise encompasses a diverse range of fields, including cardiology, with a focus on cardioprotection, and extends to neuroscience, particularly in the area of neuroprotection. His work also addresses the mechanisms underlying ischemia/reperfusion injury, contributing to a deeper understanding of both brain and cardiovascular physiology.

Top Note Publications

Title: Dunaliella salina Alga Protects against Myocardial Ischemia/Reperfusion Injury by Attenuating TLR4 Signaling

Authors: Tsai, C.-F., Lin, H.-W., Liao, J.-M., … Wang, M., Huang, S.-S.
Year: 2023
Citations: 4

Title: Lumbrokinase Regulates Endoplasmic Reticulum Stress to Improve Neurological Deficits in Ischemic Stroke

Authors: Wang, Y.-H., Liao, J.-M., Chen, K.-M., … Tsai, C.-F., Huang, S.-S.
Year: 2022
Citations: 5

Title: Activation of Peripheral TRPM8 Mitigates Ischemic Stroke by Topically Applied Menthol

Authors: Huang, S.-S., Su, H.-H., Chien, S.-Y., … Lee, H.-H., Chen, Y.-H.
Year: 2022
Citations: 14

Title: In Situ Slow-Release Recombinant Growth Differentiation Factor 11 Exhibits Therapeutic Efficacy in Ischemic Stroke

Authors: Su, H.-H., Yen, J.-C., Liao, J.-M., … Chen, Y.-H., Huang, S.-S.
Year: 2021
Citations: 5

Title: Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk

Authors: Tsai, C.-F., Su, H.-H., Chen, K., … Wang, Y.-H., Huang, S.-S.
Year: 2021
Citations: 27

Introduction of Antibiotic

Posted on by Pencis

Introduction of Antibiotic

Antibiotics are powerful medications used to treat infections caused by bacteria. They work by killing bacteria or inhibiting their growth, helping to cure infections that would otherwise become severe or life-threatening. Antibiotics have revolutionized modern medicine since their discovery, drastically reducing mortality from bacterial infections. However, the misuse and overuse of antibiotics have led to increasing levels of antibiotic resistance, posing a significant threat to global health.

  • Types of Antibiotics:
  1. Broad-spectrum Antibiotics:
    These antibiotics work against a wide variety of bacteria, both Gram-positive and Gram-negative. Examples include:

    • Amoxicillin
    • Tetracycline
    • Ciprofloxacin
  2. Narrow-spectrum Antibiotics:
    These antibiotics target specific types of bacteria. Examples include:

    • Penicillin G (used mainly against Gram-positive bacteria)
    • Vancomycin (used against resistant Gram-positive bacteria)
  3. Bactericidal Antibiotics:
    These kill bacteria by attacking their cell walls or vital cellular functions. Examples include:

    • Penicillin
    • Cephalosporins
    • Aminoglycosides
  4. Bacteriostatic Antibiotics:
    These inhibit bacterial growth by interfering with bacterial protein production or DNA replication. Examples include:

    • Tetracycline
    • Sulfonamides
    • Chloramphenicol
  • How Antibiotics Work:
  • Antibiotics target key processes in bacteria that are essential for their survival and replication. These include:
  • Cell wall synthesis inhibition: Prevents bacteria from forming cell walls, leading to cell death (e.g., Penicillin).
  • Protein synthesis inhibition: Disrupts bacterial ribosomes, which produce proteins essential for cell function (e.g., Tetracycline).
  • DNA replication inhibition: Prevents bacterial DNA replication, halting cell division (e.g., Quinolones).
  • Cell membrane disruption: Damages bacterial cell membranes, leading to cell death (e.g., Polymyxins).

    Examples of Antibiotic-Resistant Bacteria:

    1. Methicillin-resistant Staphylococcus aureus (MRSA): Resistant to many antibiotics, causing serious skin infections.
    2. Vancomycin-resistant Enterococci (VRE): Often found in hospital-acquired infections.
    3. Carbapenem-resistant Enterobacteriaceae (CRE): Highly resistant to most antibiotics and often fatal.
    4. Multidrug-resistant Mycobacterium tuberculosis (MDR-TB): Resistant to the two most powerful anti-TB drugs, requiring complex and prolonged treatment.
  • Understanding and managing animal infectious diseases is crucial for animal health, public health, and maintaining food security.

 

Introduction of Animal Infectious Diseases
Introduction of Animal infectious diseases Animal infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can affect a wide range of animal species.